PharmaTher Builds Portfolio of Personalized 3D-Printed Peptide Products
PharmaTher says it is building a portfolio of personalized, 3D-printed peptide products for a new U.S. peptide pathway, led by colon-targeted KPV and BPC-157.
PharmaTher says it is building a portfolio of personalized, 3D-printed peptide products for a new U.S. peptide pathway, led by colon-targeted KPV and BPC-157.